Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000539572 | SCV000636601 | benign | Kleefstra syndrome 1 | 2024-12-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001709664 | SCV001937144 | benign | not provided | 2019-04-22 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003243180 | SCV003943952 | likely benign | Inborn genetic diseases | 2023-05-23 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Revvity Omics, |
RCV000539572 | SCV004237832 | likely benign | Kleefstra syndrome 1 | 2023-11-10 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003979971 | SCV004789024 | likely benign | EHMT1-related disorder | 2024-02-16 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |